Lipocine Correlations
LPCN Stock | USD 4.76 0.83 14.85% |
The current 90-days correlation between Lipocine and Emergent Biosolutions is -0.12 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lipocine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lipocine moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Lipocine Correlation With Market
Good diversification
The correlation between Lipocine and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and DJI in the same portfolio, assuming nothing else is changed.
Lipocine |
Moving together with Lipocine Stock
0.66 | DMAC | DiaMedica Therapeutics Earnings Call Today | PairCorr |
0.68 | VCYT | Veracyte | PairCorr |
0.77 | DRUG | Bright Minds Biosciences | PairCorr |
0.62 | VKTX | Viking Therapeutics | PairCorr |
0.82 | VRDN | Viridian Therapeutics Earnings Call Today | PairCorr |
0.83 | VRNA | Verona Pharma PLC | PairCorr |
0.86 | VSTM | Verastem Buyout Trend | PairCorr |
Moving against Lipocine Stock
0.83 | VALN | Valneva SE ADR | PairCorr |
0.72 | VCNX | Vaccinex Earnings Call Today | PairCorr |
0.69 | ME | 23Andme Holding | PairCorr |
0.53 | DRMA | Dermata Therapeutics | PairCorr |
0.45 | VCEL | Vericel Corp Ord | PairCorr |
0.82 | VINC | Vincerx Pharma Earnings Call Tomorrow | PairCorr |
0.77 | DYAI | Dyadic International | PairCorr |
0.7 | VTGN | VistaGen Therapeutics | PairCorr |
0.69 | VNDA | Vanda Pharmaceuticals | PairCorr |
0.62 | DTIL | Precision BioSciences | PairCorr |
0.59 | VRAX | Virax Biolabs Group | PairCorr |
0.57 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.57 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.57 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.4 | VIRX | Viracta Therapeutics | PairCorr |
Related Correlations Analysis
0.17 | -0.6 | -0.18 | 0.36 | 0.77 | EBS | ||
0.17 | -0.52 | -0.03 | -0.02 | -0.2 | NBIX | ||
-0.6 | -0.52 | 0.58 | -0.5 | -0.51 | HLN | ||
-0.18 | -0.03 | 0.58 | -0.41 | -0.34 | TAK | ||
0.36 | -0.02 | -0.5 | -0.41 | 0.41 | ITCI | ||
0.77 | -0.2 | -0.51 | -0.34 | 0.41 | ALVO | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Lipocine Stock performing well and Lipocine Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lipocine's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EBS | 5.40 | 0.34 | 0.09 | 0.27 | 6.25 | 14.40 | 44.35 | |||
NBIX | 1.45 | (0.40) | 0.00 | (0.16) | 0.00 | 2.74 | 21.19 | |||
HLN | 0.72 | (0.01) | (0.15) | 0.01 | 1.04 | 1.25 | 5.26 | |||
TAK | 0.69 | 0.00 | (0.13) | 0.13 | 1.03 | 1.48 | 4.86 | |||
ITCI | 1.27 | 0.23 | 0.13 | 0.56 | 0.96 | 3.04 | 12.20 | |||
ALVO | 1.33 | 0.20 | 0.05 | 0.86 | 1.17 | 4.03 | 12.19 |
Lipocine Corporate Management
CPA CPA | Co Sec | Profile | |
Logan Morse | Marketing Sales | Profile | |
Nachiappan Chidambaram | Senior Development | Profile | |
M MD | Chief Director | Profile | |
Krista Fogarty | Principal Controller | Profile |